Sign in

NCT04876339Recruiting

Sonification Techniques for Gait Training

Sonification Techniques for Gait Training: a Pilot Multicentric Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 2 Jul 2026

Brief summary (registry, in English)

Music therapy is widely used in relational and rehabilitation settings. In addition to Neurologic Music Therapy and other music-based techniques, "sonification" approaches were recently introduced in the field of rehabilitation. The "sonification" can be defined as a properly selected set of sonorous-music stimuli are associated with patient movements mapping. In fact, the auditory-motor feedback can replace damaged proprioceptive circuits with a consequent improvement of the rehabilitation process. Interventions with "sonification" facilitate sensorimotor learning, proprioception and movements planning and execution improving global motor parameters. This study proposes the use of musical auditory cues which includes the melodic-harmonic component of the music. This kind of sonification makes the feedback pleasant and predictable as well as potentially effective. The investigators propose to apply and assess the effectiveness of this kind of sonification on gait training and other secondary outcomes in stroke, Parkinson's disease and multiple sclerosis population. Also, the investigators will assess the impact of "sonification" on the level of fatigue perceived during the rehabilitation process and on the quality of life. The study is a multicenter randomized controlled trial and will involve 120 patients that will undergo standard motor rehabilitation or the same rehabilitation but with the sonification support. The interventions will be evaluated at the baseline, after 10 sessions, after 20 sessions and at follow-up (one month after the end of the treatment). The assessment will include functional, motor, fatigue and quality of life evaluations. The collected data will be statistically processed.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
26 Apr 2021
Start date
18 Jan 2021
Primary completion date
31 Dec 2026
Lead sponsor
Istituti Clinici Scientifici Maugeri SpA
NCT number
NCT04876339

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 18 Jan 2021 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Neurotoxin in the 3 months prior to the study
  • Baclofen introduced or modified in the week before the start of the study
  • Previous or concurrent diseases disabling the lower limb functions
  • Previous or concurrent diseases disabling the lower limb functions
  • Changes of drug therapy during the study
  • Previous or concurrent diseases disabling the lower limb functions
  • Neurotoxin in the 3 months prior to the study
  • Baclofen introduced or modified in the week before the start of the study

Other

  • Multiple or bilateral lesions
  • Neglect
  • Equinism
  • Spasticity: Ashworth \>2
  • Structured (non-elastic) Achilles tendon retraction
  • Rehabilitative treatments with music in the year before the study
  • Rehabilitative treatments with music in the year before the study
  • Spasticity: Ashworth \>2
  • Structured (non-elastic) Achilles tendon retraction
  • Rehabilitative treatments with music in the year before the study

Who the study is looking for

  • Age \< 80
  • Mini Mental State Examination \> 24
  • Modified Rankin Scale: 1-3
  • Single hemisphere lesion
  • Stabilized disease (\> 6 months after the acute event)
  • Impairment in gait parameters (e.g. velocity, perceived fatigue etc)
  • Motor independence during walking (without orthotic devices and aids) but with pathological pattern (spasticity level: Ashworth \< 2)
  • Age \< 80
  • Mini Mental State Examination \> 24
  • Unified Parkinson Disease Rating Scale score (Parte III): \< 28
  • Stabilized disease and drug therapy
  • Altered gait patterns
  • Motor independence during walking (without orthotic devices and aids) but with pathological pattern
  • Age \< 60
  • Mini Mental State Examination \> 24
  • Expanded Disability Status Scale score: 3-5
  • Stabilized disease in the last 6 months (without relapse or disability progression)
  • Altered gait patterns (i.e., careening, slowing down, spasticity: Ashworth \< 2, etc.)
  • Motor independence during walking

Age in the registry: - to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Istituti Clinici Scientifici Maugeri IRCCS
Coordinator of this site? Confirm its status
PaviaItalyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.